Table-II.

Comparative analysis of T lymphocyte subpopulations in two groups before the treatment (X̅ ±S) n=40.

Indicator		Experimental Group Δ	Control Group Δ	t	p
CD3+(%)	Pre*	40.57±8.25	40.21±7.85	0.91	0.37
	PostΔ	48.64±9.73	44.73±8.07	2.45	0.02
	t	4.00	2.54
	p	0.00	0.01
CD4+(%)	Pre*	28.76±5.64	28.54±6.49	0.16	0.87
	PostΔ	36.85±6.07	32.91±6.33	2.84	0.00
	t	6.18	3.05
	p	0.00	0.00
CD8+(%)	Pre*	20.55±3.57	20.67±4.42	0.13	0.89
	PostΔ	21.87±4.35	22.65±5.07	0.74	0.46
	t*	1.48	1.86
	p*	0.14	0.06
CD4+/CD8+	Pre*	1.25±0.35	1.21±0.56	0.38	0.70
	PostΔ	1.56±0.21	1.42±0.27	2.58	0.01
	t	4.80	2.14
	p	0.00	0.04

^*p>0.05, Δp<0.05.